Home » Topics » BioWorld Science

BioWorld Science
RSS

Preliminary results indicate potential for AML treatment

May 21, 1997

Preliminary phase I/II results for Vertex's VX-710

May 21, 1997

NIH funds Cognetix's research on antiseizure drug

May 21, 1997

Techniclone reports promising results from brain cancer treatment study

May 21, 1997

Rhone-Poulenc Rorer launches Zagam in the U.S.

May 21, 1997

Company Profile: MitoKor

May 21, 1997

Somatix reports promising results from melanoma vaccine trials

May 21, 1997

Serzone superior to Prozac in the treatment of sleep disturbances in depressed patients

May 21, 1997

Biomet and Merck KGaA to form joint venture

May 21, 1997

DepoMed seeks alliances for drug delivery systems

May 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...